Drug class in one race
MEK (MAP2K1/2) drugs for Non-Small Cell Lung Cancer
2 tracked MEK (MAP2K1/2) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the MEK (MAP2K1/2) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/21 Phase 1